Page 130 - product-manual
P. 130

TM/MC  TM/MC
                                                                                             REFERENCES (cont’d)






            Villalobos ME, Sánchez-Muniz FJ, Acín MT, et al. (2010). Similarities, differences and agonisms of pleiotropic effects of statins and omega-3 fatty acids (in Spanish).
            Nutricion Hospitalaria. 25:889-909.

            Waldron MK, Spencer AL, Bauer JE. (1998). Role of long-chain polyunsaturated n-3 fatty acids in the development of the nervous system of dogs and cats. Journal of the
            American Veterinary Medical Association. 213:619-22.

            Wander RC, Hall JA, Gradin JL, et al. (1997). The ratio of dietary (n-6) to (n-3) fatty acids influences immune system function, eicosanoid
            metabolism, lipid peroxidation and vitamin E status in aged dogs. The Journal of Nutrition. 127:1198-205.

            Wilkins C, Long RC Jr, Waldron M, et al. (2004).  Assessment of the influence of fatty acids on indices of insulin sensitivity and myocellular lipid content by use of magnetic
            resonance spectroscopy in cats. American Journal of Veterinary Research. 65:1090-9.

            Williams JH. (1998). The use of gamma linolenic acid, linoleic acid and natural vitamin E for the treatment of multicentric lymphoma in two dogs. Journal of the South
            African Veterinary Association. 59:141-4.

            Wynter MP, Russell ST, Tisdale MJ. (2004). Effect of n-3 fatty acids on the antitumour effects of cytotoxic drugs. In Vivo. 18:543-7.

























































                                                                                               Omega3/6/9 -VM TM       |  9
   125   126   127   128   129   130   131   132   133   134   135